FTVSX | VMVAX | FTVSX / VMVAX | |
Total Expense Ratio | 0.85 | 0.07 | 1,214% |
Annual Report Gross Expense Ratio | 1.03 | 0.07 | 1,471% |
Fund Existence | 8 years | 14 years | - |
Gain YTD | 0.736 | 5.198 | 14% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 3000 | 3,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 407M | 31B | 1% |
Annual Yield % from dividends | 1.41 | 2.22 | 64% |
Returns for 1 year | 2.52 | 7.67 | 33% |
Returns for 3 years | 12.36 | 17.51 | 71% |
Returns for 5 years | 80.15 | 65.15 | 123% |
Returns for 10 years | N/A | 87.87 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IQSI | 33.86 | 0.21 | +0.64% |
NYLI Candriam International Equity ETF | |||
CPSM | 28.07 | -0.01 | -0.04% |
Calamos S&P 500 Str Alt Prt ETF-May | |||
SCHX | 25.47 | -0.06 | -0.24% |
Schwab US Large-Cap ETF™ | |||
CHY | 10.84 | -0.03 | -0.28% |
Calamos Convertible and High Income Fund | |||
NULC | 50.47 | -0.26 | -0.51% |
Nuveen ESG Large-Cap ETF |